Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11021513 Peptidomimetics for the treatment of norovirus infection

Patent 11021513 was granted and assigned to Emory University on June, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Emory University

0

Current Assignee

Emory University

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Bradley J. Keusch0

Benjamin D. Kuiper0

Franck Amblard0

Ladislau Kovari0

Peng Liu0

Raymond F. Schinazi0

Shaoman Zhou0

Date of Patent

June 1, 2021

0

Patent Application Number

163011680

Date Filed

May 15, 2017

0

Patent Citations Received

US Patent 11919910 Spiropyrrolidine derived antiviral agents

0

US Patent 11912714 Spiropyrrolidine derived antiviral agents

0

US Patent 11976084 Spiropyrrolidine derived antiviral agents

0

US Patent 11319325 Macrocyclic spiropyrrolidine derived antiviral agents

US Patent 11325916 Spiropyrrolidine derived antiviral agents

US Patent 11339170 Spiropyrrolidine derived antiviral agents

US Patent 11352363 Spiropyrrolidine derived antiviral agents

US Patent 11858945 Alkyne-containing antiviral agents

0

...

Patent Primary Examiner

Sudhakar Katakam

0

Patent abstract

The present invention is directed to compounds, compositions and methods for preventing, treating or curing Norovirus infection in human subjects or other animal hosts.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11021513 Peptidomimetics for the treatment of norovirus infection

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.